Cytosorbents (CTSO) Revenue Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | -2.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11% |
| Dec 31, 2025 | -0.56% |
| Sep 30, 2025 | 5.35% |
| Jun 30, 2025 | 4.22% |
| Mar 31, 2025 | 0.14% |
| Dec 31, 2024 | -5.32% |
| Sep 30, 2024 | -4.08% |
| Jun 30, 2024 | -9.74% |
| Mar 31, 2024 | -5.34% |
| Dec 31, 2023 | -10.16% |
| Sep 30, 2023 | -5.82% |
| Jun 30, 2023 | -1.29% |
| Mar 31, 2023 | 2.76% |
| Dec 31, 2022 | 8.12% |
| Sep 30, 2022 | 10.00% |
| Jun 30, 2022 | 10.88% |
| Mar 31, 2022 | 18.74% |
| Dec 31, 2021 | 21.04% |
| Sep 30, 2021 | 19.34% |
| Jun 30, 2021 | 27.84% |
| Mar 31, 2021 | 29.11% |
| Dec 31, 2020 | 37.03% |
| Sep 30, 2020 | 40.23% |
| Jun 30, 2020 | 40.04% |
| Mar 31, 2020 | 40.89% |
| Dec 31, 2019 | 34.07% |
| Sep 30, 2019 | 36.21% |
| Jun 30, 2019 | 41.02% |
| Mar 31, 2019 | 42.08% |
| Dec 31, 2018 | 51.15% |
| Sep 30, 2018 | 62.29% |
| Jun 30, 2018 | 81.42% |
| Mar 31, 2018 | 89.55% |
| Dec 31, 2017 | 74.56% |
| Sep 30, 2017 | 48.73% |
| Jun 30, 2017 | 51.55% |
| Mar 31, 2017 | 43.12% |
| Dec 31, 2016 | 17.21% |
| Sep 30, 2016 | 52.72% |
| Jun 30, 2016 | 158.96% |
| Mar 31, 2016 | 117.43% |
| Dec 31, 2015 | 171.53% |
| Sep 30, 2015 | 361.40% |
| Jun 30, 2015 | 168.14% |
| Mar 31, 2015 | 143.27% |
| Dec 31, 2014 | 189.31% |